Navigation Links
BD Increases Haiti Relief Fund to Include $5 Million in Product Donations

FRANKLIN LAKES, N.J., Jan. 27 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is increasing the supply of its products available for donation in support of Haiti earthquake relief efforts from the $500,000 announced on January 15 to $5 million in market value of critical medical supplies.  This additional commitment will help BD's nonprofit partner organizations use and provide BD products they have specifically requested to address the healthcare disaster and ongoing needs in Haiti.

BD regularly pre-positions product donations with AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International and Project HOPE to enable these nonprofit organizations to respond swiftly in disaster situations around the world, such as the Haiti earthquake.  To date, these groups have distributed I.V. catheters, antimicrobial scrub brushes and antiseptic, needles and syringes, and various other BD products in Haiti. BD will continue to work with these nonprofit agencies as they conduct ongoing needs assessments for critical products.

This increase in BD's product donation commitment augments the $1.2 million fund BD initially established for Haiti relief efforts and brings the total to $5.7 million. In addition to products, as previously announced, BD is donating $550,000 in cash to nine humanitarian aid partner organizations (American Red Cross, AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International, Partners In Health, Project HOPE, Save the Children and the U.S. Fund for UNICEF) and matching up to $150,000 in donations from BD associates worldwide to the U.S. Fund for UNICEF; this match is in addition to BD's traditional Matching Gift Program.

As a member of the Partnership for Quality Medical Donations, BD is distributing its donations among its pre-approved nonprofit partners, which share a commitment to the World Health Organization's guidelines on appropriate product donation practices.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit

SOURCE BD (Becton, Dickinson and Company)



SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
2. Hanger Orthopedic Group Increases Q4 2009 Sales and EPS Guidance
3. CVS Caremark Corporation Increases Quarterly Dividend 15%
4. EvoLucia(TM) LED Lighting Saves Energy, Increases Security at Sarasota Hospital
5. WellTek Subsidiary MedX Limited Increases Presence in Global Market
6. ScandiDos Sells 100th Delta4(R) PT Unit as Adoption of Rotational Therapy Cancer Treatment Increases
7. Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients
8. Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
9. West Increases Quarterly Dividend to $0.16
10. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
11. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
Post Your Comments:
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... Pennsylvania , November 25, 2015 - ... Continuing Medical Education (CME) --> ... Continuing Medical Education (CME) --> ... Care Continuing Medical Education (CME) ... medical information products and services, will feature latest diagnostic imaging textbooks ...
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm ... appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto ... Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately ... has undertaken significant expansion of its current state of the art research, development ... PharmaTech’s strategy to increase its manufacturing capacity as well as to support its ...
(Date:11/25/2015)... ... 2015 , ... Since its launch in 2012, the Regenestem ... cell therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent ... (RTM). , Organizations are required to hold a registered trademark in order to ...
Breaking Medicine News(10 mins):